振德医疗 (603301.SH)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(单季度)(振德医疗)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年第三季度2024年第二季度2024年第一季度2023年第四季度2023年第三季度2023年第二季度2023年第一季度
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 1,082,970,366.621,078,532,286.04963,887,437.65917,849,234.37903,054,567.591,005,663,456.861,300,476,798.62
 营业收入(元) 1,082,970,366.621,078,532,286.04963,887,437.65917,849,234.37903,054,567.591,005,663,456.861,300,476,798.62
二、营业总成本(元) 1,000,564,507.03962,733,528.95870,157,936.80867,669,614.50822,073,407.38917,277,694.691,133,257,765.70
 营业成本(元) 717,222,646.51690,998,065.84628,159,512.79587,333,779.72602,165,827.75667,644,639.55837,466,371.47
 研发费用(元) 36,420,654.6832,958,491.4229,493,825.7928,499,131.4728,199,143.4640,154,277.6642,093,960.50
 营业税金及附加(元) 9,024,806.9412,433,778.988,176,728.108,716,849.917,133,066.975,816,925.4811,412,432.41
 销售费用(元) 81,586,547.4889,702,284.5088,962,815.8793,209,077.2871,811,141.02100,150,592.60116,083,806.56
 管理费用(元) 132,155,140.45136,962,022.90125,807,862.59142,130,017.35116,928,411.93121,853,060.47132,274,439.42
 财务费用(元) 24,154,710.97-321,114.69-10,442,808.347,780,758.77-4,164,183.75-18,341,801.07-6,073,244.66
  其中:利息费用(元) 7,526,978.487,783,432.688,617,084.425,896,751.316,552,567.978,878,242.257,601,281.26
  其中:利息收入(元) 5,265,581.527,351,026.179,129,586.635,578,933.179,385,690.9511,147,901.4713,842,390.11
 资产减值损失(元) -4,125,776.83-6,994,655.56-15,011,076.66-165,125,644.26-15,505,916.72-26,853,237.2925,187.76
 信用减值损失(元) -567,983.09-5,516,344.87-3,881,072.47-5,586,359.25-2,805,025.357,923,511.52-1,335,624.79
三、其他经营收益
 加:公允价值变动收益(元) -1,988,724.89914,386.16-1,841,014.94-13,139,841.035,980,414.09-28,511,780.6914,606,416.45
 加:投资收益(元) 7,300,384.34509,993.91764,903.2723,140,595.86-7,824,472.522,081,892.31-10,597,037.66
  其中:对联营企业和合营企业的投资收益(元) 30,836.10-365,223.27-27,659.25-8,208.90-228,230.3741,774.04-437,587.66
 资产处置收益(元) 99,206,089.63-220,318.98308,314.22-15,795,883.45-50,524.64165,787.86-283,961.95
 其他收益(元) 12,400,115.3310,990,716.7011,704,234.3420,735,169.886,659,100.9147,196,548.844,083,356.56
四、营业利润(元) 194,629,964.08115,482,534.4585,773,788.61-105,592,342.3867,434,735.9890,388,484.72173,717,369.29
 加:营业外收入(元) 336,843.74-9,749.5729,871.37-389,268.78394,689.52276,498.98380,980.83
 减:营业外支出(元) 11,971,052.772,685,431.27767,328.091,622,776.752,986,815.97567,184.982,542,074.27
五、利润总额(元) 182,995,755.05112,787,353.6185,036,331.89-107,604,387.9164,842,609.5390,097,798.72171,556,275.85
 减:所得税费用(元) 32,808,996.5220,729,867.459,806,221.72-12,258,945.55-1,071,778.90-4,747,963.0123,571,134.90
六、净利润(元) 150,186,758.5392,057,486.1675,230,110.17-95,345,442.3665,914,388.4394,845,761.73147,985,140.95
(一)按经营持续性分类
  持续经营净利润(元) 150,186,758.5392,057,486.1675,230,110.17-95,345,442.3665,914,388.4394,845,761.73147,985,140.95
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 146,351,133.8587,711,474.2973,397,631.01-102,122,440.8163,155,119.1190,904,854.26146,461,478.20
  少数股东损益(元) 3,835,624.684,346,011.871,832,479.166,776,998.452,759,269.323,940,907.471,523,662.75
 扣除非经常性损益后的净利润(元) 63,562,176.8486,848,029.8174,696,045.21-93,871,250.5860,425,430.3382,127,747.82140,905,813.96
七、每股收益
 一、基本每股收益(元) 0.550.320.28-0.390.240.340.55
 二、稀释每股收益(元) 0.550.320.28-0.390.240.340.55
八、其他综合收益(元) 13,716,073.34-1,850,865.8737,701,731.115,293,874.02-21,620,397.8814,970,827.3821,144,731.83
 归属于母公司股东的其他综合收益(元) 6,081,882.756,399,619.8929,681,539.60-1,030,613.91-13,482,319.572,443,283.8317,972,140.47
 归属于少数股东的其他综合收益(元) 7,634,190.59-8,250,485.768,020,191.516,324,487.93-8,138,078.3112,527,543.553,172,591.36
九、综合收益总额(元) 163,902,831.8790,206,620.29112,931,841.28-90,051,568.3444,293,990.55109,816,589.11169,129,872.78
 归属于母公司所有者的综合收益总额(元) 152,433,016.6094,111,094.18103,079,170.61-103,153,054.7249,672,799.5493,348,138.09164,433,618.67
 归属于少数股东的综合收益总额(元) 11,469,815.27-3,904,473.899,852,670.6713,101,486.38-5,378,808.9916,468,451.024,696,254.11
公告日期 2024-10-302024-08-302024-04-272024-04-272023-10-312023-08-302023-04-26
审计意见(境内) 标准无保留意见

前瞻产业研究院